Download Non-Contrast MRA - SCBT-MR

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Electrocardiography wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Jatene procedure wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Transcript
Non-Contrast MR Angiography
Robert R. Edelman, M.D.
Dept. of Radiology
NorthShore University HealthSystem
Feinberg School of Medicine, Northwestern University
Nephrogenic Systemic Fibrosis:
Game-changer for CE-MRA
• NSF can be prevented with simple precautions,
but damage is already done…
• The “go to” imaging test for patients with impaired renal
function is now viewed by many clinicians as hazardous
• Decreased referrals for renal and peripheral MRA
– hard to recapture patients
• Substantial additional cost for POS eGFR testing equipment
Up to 50% Reduction in Contrast Agent Dose For 3T MRA
Total of 20cc GdDTPA
(dual bolus, 3 stations)
Finn JP et al. Radiology
2008; 248:680
Use of Higher Relaxivity Contrast Agent Allows
Decreased Dosage
Gadopentetate
dimeglumine
Gadobenate
dimeglumine
Gadopentetate
dimeglumine
Gadobenate
dimeglumine
Knopp MV et al. J Magn Reson Imaging. 2003;17:694-702.
Gadopentetate
dimeglumine
Gadobenate
dimeglumine
Whole body MR MRA/MRV with
Ferumoxytol (Equilibrium Phase)
Total Acquisition Time:
5minutes 45 seconds
for 8 stations
*Note lack of renal parenchymal enhancement
How About Not Using Any Contrast Agent
for MRA?
Potential contrast mechanisms for unenhanced MRA:
¾ Gated Subtraction (subtraction of images acquired at
different phases of the cardiac cycle)
¾ Spin-Labeling (subtraction of image sets prepared by
different RF pulses)
¾ Time-Of-Flight (TOF) effects
¾ Phase-Contrast
¾ Flow-independent mechanisms
Time of Flight Non-Contrast MRA
Good for Intracranial Vessels…….Bad for Vessels in Body
bSSFP: Improve Background Suppression Using an Inversion Pulse
time-SLIP, native trueFISP
Takahashi J et al. Proceedings of Annual Mtg ISMRM 2007:179
Native trueFISP MRA with Navigator Gating
•X. Bi, PhD Siemens Medical Solutions
Renal Transplant
CE-MRA
NC-MRA
Gated Subtractive MRA
• Fresh Blood Imaging (FBI): TurboSE readout (1)
• Flow-sensitive Dephasing (FSD): bSSFP readout (2)
Diastole
Systole
1. Miyazaki et al. Radiology 2003; 227:890-896
2. Fan et al. Magn Reson Med 2009; 62:1523–1532.
Fresh Blood Imaging
•Uses 3D Half-Fourier
fast SE for data acquisition
• Use cine PC to
determine ECG delay
for maximum and
minimum flow velocity
• Subtraction shows
arteries while eliminating
background tissues
• Scan time only a few
minutes
• Sensitivity/specificity for
>50% stenosis 94%/94%
Miyazaki et al. Radiology 227:890-896, 2003;
Proc. ISMRM 14 (2006):1929
Ideal Methodology for
Unenhanced MRA
•
•
•
Fast
Easy to use
Insensitive to:
•
•
•
•
Patient motion
Heart rate
Flow patterns
Robust imaging of pelvis arteries
9
Quiescent Interval
Single Shot (QISS) MRA:
Multi-station Acquisition Method
8
7
6
5
4
3
2
1
QISS
3x1x1mm
Axial
Dist= 0
400 matrix
40cm fov
QISS
1.2x1x1mm
Axial
Dist= -20
400 matrix
40cm fov
PATIENT JR
87 YEAR OLD MALE
ACHING LEGS
ATRIAL FIBRILLATION
QISS MRA
CE-MRA
Patient KW
66 year old male
Bilateral claudication
QISS MRA
CE-MRA
QISS
MRA
CE‐MRA
QISS
Patient NC
88 year old male with
claudication, diabetes and
atrial fibrillation
CTA
ZERO DOSE (QISS) MRA STRATEGY
Sensitivity 93.9%
Specificity 90.6%
Sensitivity 95.8%
Sensitivity 96.4%
Specificity 89.3%
Specificity 92.4%
NPV 96.7%
PPV 89.8%
Sensitivity 96.5%
Specificity 95.8%
2DTOF
QISS
Arterial Spin Labeling:
20 Second “STAR” Non-Contrast Carotid MRA
Diffeence
Of tagged and
Untagged Images
Inversion tagging pulse
Koktzoglou , Edelman ENH
Arterial Spin-Labeled MRA (ASL)
baseline image
tagged image
direction
of blood
flow
arterial
arterial segment
segment
of
of interest
interest
• Contrast predicated on differential vascular signal
created by preparatory RF pulses
tag
artery
R
R
ECG
ECG
RF
RF tag
tag
baseline
baseline image
image
tagged
tagged image
image
Dixon et al. Magn Reson
Med 1986; 3:454-462
Non-Contrast MRA
of the Hands
Using FSD
Patient 3
Severe disease
CE-MRA
Non-contrast MRA
Direct Thrombus Imaging
Fraser D et al. Ann Intern Med. 2002;136:89-98
• All clots > 8 hours appeared bright with water-excite
MP-RAGE sequence
• Sens/spec within each of the venous segments ranged from
91% to 100%; same below knee (101 patients)
Steady State Free Precession (SSFP)-Based
MR Venography
Cantwell CP et al. JVIR 2006; 17:1763–1769
Flow-Independent MRA:
STARFIRE
Non-Contrast Evaluation of Acute DVT
Water-excite MP-RAGE
STARFIRE
Dbl dose Gd-3DMRA
delayed - arterial
Pitfalls of Non-Contrast MRA
• Stenosis exaggeration from accelerating or turbulent flow
with bSSFP and turboSE readouts
• Sensitivity of bSSFP sequences to B0 inhomogeneity
• Mistiming of delays for peak and minimal flow velocities
with FBI/native SPACE
• ECG mis-triggering
• Stair-step artifact with 2D acquisitions
Conclusions
• NSF has changed landscape for MR angiography
• Contrast-enhanced MRA can be safely performed
and NSF entirely avoided if proper screening procedures
are undertaken and appropriate contrast agents
are used (but remains disruptive to work flow)
• Newer non-contrast MRA techniques may permit
screening for vascular disease with high negative
predictive value, thereby eliminating need for contrast
agents in many if not most cases
• Only limited clinical validation has been published:
lack of technique uniformity across vendors
• With proper validation, will likely reduce or eliminate need for
contrast agents in many MRA applications, thereby reducing cost
and morbidity
Acknowledgments
•
•
•
•
•
•
Ioannis Koktzoglou, Ph.D. NorthShore
Philip Hodnett, M.D. NorthShore/NMH
John Sheehan, M.D. NorthShore
Debiao Li, Ph.D. NMH
Xiaoming Bi, Ph.D. Siemens Healthcare
Christopher Glielmi, Ph.D. Siemens Healthcare